logo

DNA

Ginkgo Bioworks·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

DNA fundamentals

Ginkgo Bioworks (DNA) released its earnings on Nov 6, 2025: revenue was 38.84M (YoY -56.38%), missed estimates; EPS was -1.45 (YoY -34.26%), missed estimates.
Revenue / YoY
38.84M
-56.38%
EPS / YoY
-1.45
-34.26%
Report date
Nov 6, 2025
DNA Earnings Call Summary for Q3,2025
  • AI Lab Automation: Ginkgo's RAC system enables AI models to control lab experiments via standardized robotics.
  • Government Growth: 20%+ revenue from U.S. grants, $22M BARDA award for antibody manufacturing.
  • Cash Efficiency: Q3 2025 cash burn $28M (-75% YoY), $462M cash with no debt.
  • Future Labs Partnership: Collaborating with FutureHouse to develop AI scientists that design and execute experiments.
EPS
Revenue

Revenue & Expenses

DNA has released its 2025 Q3 earnings report, with revenue of 38.84M, reflecting a YoY change of -56.39%, and net profit of -80.75M, showing a YoY change of -43.18%. The Sankey diagram below clearly presents DNA's revenue sources and cost distribution.

Key Indicators

Ginkgo Bioworks (DNA) key financial stats and ratios, covering profitability, financial health, and leverage.
Ginkgo Bioworks (DNA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ginkgo Bioworks (DNA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ginkgo Bioworks (DNA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ginkgo Bioworks (DNA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ginkgo Bioworks (DNA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield